Use of genetic variants in wnt signaling pathway to predict gender and tumor location dependent survival in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (BEV).
Yan Ning
No relevant relationships to disclose
Wu Zhang
No relevant relationships to disclose
Dongyun Yang
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
Takeru Wakatsuki
No relevant relationships to disclose
Sebastian Stintzing
No relevant relationships to disclose
Nico Benjamin Volz
No relevant relationships to disclose
Joseph Ethan Li
No relevant relationships to disclose
Rita Elie El-Khoueiry
No relevant relationships to disclose
Melissa Janae Labonte
No relevant relationships to disclose
Chiara Cremolini
No relevant relationships to disclose
Federica Marmorino
No relevant relationships to disclose
Afsaneh Barzi
No relevant relationships to disclose
Anthony B. El-Khoueiry
No relevant relationships to disclose
Heinz-Josef Lenz
Consultant or Advisory Role - Genentech (U)
Honoraria - Genentech
Michael Kahn
No relevant relationships to disclose